During the past decade, Sooner Clinical Research conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 28 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 16 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sooner Clinical Research" #1 sponsor was "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 6 trials, followed by "Sunovion" with 6 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 4 trials sponsored and "Bausch Health Americas, Inc." with 4 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sooner Clinical Research" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Neumora Therapeutics, Inc." with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator, "RTI Health Solutions" with 1 trials as a collaborator and "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Sooner Clinical Research" are "Depressive Disorder, Major" (8 trials), "Major Depressive Disorder" (7 trials), "Ulcerative Colitis" (3 trials), "Bipolar Disorder" (2 trials) and "Depressive Episodes, Bipolar I Depression" (2 trials). Many other conditions were trialed in "Sooner Clinical Research" in a lesser frequency.

Most popular intervention types in "Sooner Clinical Research" are "Drug" (48 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Rapastinel" (4 trials), "placebo" (4 trials), "Aticaprant" (2 trials) and "Cariprazine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sooner Clinical Research" are 46 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Sooner Clinical Research". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 35 completed trials in Sooner Clinical Research, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Sooner Clinical Research, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".